156 related articles for article (PubMed ID: 31452172)
1. In Vitro Culture of Cryptosporidium parvum Using Stem Cell-Derived Intestinal Epithelial Monolayers.
Wilke G; Wang Y; Ravindran S; Stappenbeck T; Witola WH; Sibley LD
Methods Mol Biol; 2020; 2052():351-372. PubMed ID: 31452172
[TBL] [Abstract][Full Text] [Related]
2. Two- and Three-Dimensional Bioengineered Human Intestinal Tissue Models for Cryptosporidium.
Cardenas D; Bhalchandra S; Lamisere H; Chen Y; Zeng XL; Ramani S; Karandikar UC; Kaplan DL; Estes MK; Ward HD
Methods Mol Biol; 2020; 2052():373-402. PubMed ID: 31452173
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta1 ameliorates intestinal epithelial barrier disruption by Cryptosporidium parvum in vitro in the absence of mucosal T lymphocytes.
Roche JK; Martins CA; Cosme R; Fayer R; Guerrant RL
Infect Immun; 2000 Oct; 68(10):5635-44. PubMed ID: 10992464
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Culture of Cryptosporidium parvum Using Hollow Fiber Bioreactor: Applications for Simultaneous Pharmacokinetic and Pharmacodynamic Evaluation of Test Compounds.
Yarlett N; Morada M; Gobin M; Van Voorhis W; Arnold S
Methods Mol Biol; 2020; 2052():335-350. PubMed ID: 31452171
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome analysis of pig intestinal cell monolayers infected with Cryptosporidium parvum asexual stages.
Mirhashemi ME; Noubary F; Chapman-Bonofiglio S; Tzipori S; Huggins GS; Widmer G
Parasit Vectors; 2018 Mar; 11(1):176. PubMed ID: 29530089
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells.
VanDussen KL; Funkhouser-Jones LJ; Akey ME; Schaefer DA; Ackman K; Riggs MW; Stappenbeck TS; Sibley LD
mBio; 2020 Dec; 11(6):. PubMed ID: 33323514
[TBL] [Abstract][Full Text] [Related]
7. Human primary intestinal epithelial cells as an improved in vitro model for Cryptosporidium parvum infection.
Castellanos-Gonzalez A; Cabada MM; Nichols J; Gomez G; White AC
Infect Immun; 2013 Jun; 81(6):1996-2001. PubMed ID: 23509153
[TBL] [Abstract][Full Text] [Related]
8. Labeling surface epitopes to identify Cryptosporidium life stages using a scanning electron microscopy-based immunogold approach.
Edwards H; Thompson RC; Koh WH; Clode PL
Mol Cell Probes; 2012 Feb; 26(1):21-8. PubMed ID: 22100878
[TBL] [Abstract][Full Text] [Related]
9. Complete development of Cryptosporidium parvum in rabbit chondrocytes (VELI cells).
Lacharme L; Villar V; Rojo-Vazquez FA; Suárez S
Microbes Infect; 2004 May; 6(6):566-71. PubMed ID: 15158190
[TBL] [Abstract][Full Text] [Related]
10. Preferential infection of dividing cells by Cryptosporidium parvum.
Widmer G; Yang YL; Bonilla R; Tanriverdi S; Ciociola KM
Parasitology; 2006 Aug; 133(Pt 2):131-8. PubMed ID: 16623967
[TBL] [Abstract][Full Text] [Related]
11. Morphological characterization of Cryptosporidium parvum life-cycle stages in an in vitro model system.
Borowski H; Thompson RC; Armstrong T; Clode PL
Parasitology; 2010 Jan; 137(1):13-26. PubMed ID: 19691870
[TBL] [Abstract][Full Text] [Related]
12. Cryptosporidium parvum disrupts intestinal epithelial barrier in neonatal mice through downregulation of cell junction molecules.
Luo C; Xu Y; Zhang J; Tian Q; Guo Y; Li N; Feng Y; Xu R; Xiao L
PLoS Negl Trop Dis; 2024 May; 18(5):e0012212. PubMed ID: 38787872
[TBL] [Abstract][Full Text] [Related]
13. Host intestinal epithelial response to Cryptosporidium parvum.
Deng M; Rutherford MS; Abrahamsen MS
Adv Drug Deliv Rev; 2004 Apr; 56(6):869-84. PubMed ID: 15063595
[TBL] [Abstract][Full Text] [Related]
14. Assessment of differences between DNA content of cell-cultured and freely suspended oocysts of Cryptosporidium parvum and their suitability as DNA standards in qPCR.
Woolsey ID; Blomstrand B; Øines Ø; Enemark HL
Parasit Vectors; 2019 Dec; 12(1):596. PubMed ID: 31856894
[TBL] [Abstract][Full Text] [Related]
15. Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth
Funkhouser-Jones LJ; Ravindran S; Sibley LD
mBio; 2020 Mar; 11(2):. PubMed ID: 32127445
[No Abstract] [Full Text] [Related]
16. Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression
Wilke G; Ravindran S; Funkhouser-Jones L; Barks J; Wang Q; VanDussen KL; Stappenbeck TS; Kuhlenschmidt TB; Kuhlenschmidt MS; Sibley LD
mSphere; 2018 Jun; 3(3):. PubMed ID: 29848759
[TBL] [Abstract][Full Text] [Related]
17. Host cell apoptosis impairs Cryptosporidium parvum development in vitro.
Widmer G; Corey EA; Stein B; Griffiths JK; Tzipori S
J Parasitol; 2000 Oct; 86(5):922-8. PubMed ID: 11128511
[TBL] [Abstract][Full Text] [Related]
18. Cryptosporidium parvum infection induces autophagy in intestinal epithelial cells.
Priyamvada S; Jayawardena D; Bhalala J; Kumar A; Anbazhagan AN; Alrefai WA; Borthakur A; Dudeja PK
Cell Microbiol; 2021 Apr; 23(4):e13298. PubMed ID: 33237610
[TBL] [Abstract][Full Text] [Related]
19. [Improvement of amplification method for Cryptosporidium parvum oocysts from mice].
Huang KH; Yang SG; Tang JX
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(6):360-2. PubMed ID: 12572074
[TBL] [Abstract][Full Text] [Related]
20. Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture.
Hijjawi NS; Meloni BP; Morgan UM; Thompson RC
Int J Parasitol; 2001 Aug; 31(10):1048-55. PubMed ID: 11429168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
